Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Raynaud's Phenomenon in Scleroderma
IRCT20081202001479N7Phase 4Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of botulinum toxin type A in Raynaud disease and systemic sclerosis (SSc), sponsored by Mashhad University of Medical Sciences. Started Jan 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Raynaud diseasesystemic sclerosis (SSc)
Beyond the preview
Go deeper on IRCT20081202001479N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20081202001479N7.